Yüklüyor......
Targeting ALK in neuroblastoma—preclinical and clinical advancements
Despite improvements in cancer therapies in the past 50 years, neuroblastoma remains a devastating clinical problem and a leading cause of childhood cancer deaths. Advances in treatments for children with high-risk neuroblastoma have, until recently, involved addition of cytotoxic therapy to dose-in...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3683972/ https://ncbi.nlm.nih.gov/pubmed/22585002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2012.72 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|